Community-associated methicillin-resistant Staphylococcus aureus infections

British Medical Bulletin

Volumn 94, Issue 1, 2010, Pages 215-227

  Cooke, Fiona J ^a,b   Brown, Nicholas M ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Community; Genomics; Methicillin resistance; MRSA; Necrotizing pneumonia; Review; Skin and soft tissue infections; Staphylococcus aureus; Staphylococcus chromosomal cassette

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPTOMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; TRIMETHOPRIM; VANCOMYCIN; VIRULENCE FACTOR; ANTIINFECTIVE AGENT;

ABSCESS; AGE DISTRIBUTION; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL CHROMOSOME; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CELLULITIS; COMMUNICABLE DISEASE; DISEASE SEVERITY; DRUG MEGADOSE; ETHNIC DIFFERENCE; EUROPE; GENE CASSETTE; GENE SEQUENCE; GENOMICS; GENOTYPE; GROUP A STREPTOCOCCAL INFECTION; HIGH RISK POPULATION; HORIZONTAL GENE TRANSFER; HOSPITAL INFECTION; HUMAN; LENGTH OF STAY; MALE HOMOSEXUAL; MATHEMATICAL MODEL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; NOSE SMEAR; PHENOTYPE; PNEUMONIA; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEX DIFFERENCE; SKIN INFECTION; SOFT TISSUE INFECTION; UNITED STATES; COMMUNITY-ACQUIRED INFECTIONS; GENETICS; GENOME; METABOLISM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; GENOME; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS;

EID: 77952980831     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldq010     Document Type: Review

References (37)

1. Zetola N, Francis JS, Nuermberger EL et al. Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005;5:275-286
2. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009;7:629-641
3. Buck JM, Como-Sabetti K, Harriman KH et al. Community-associated methicillin-resistant Staphylococcus aureus, Minnesota, 2000-2003. Emerg Infect Dis 2005;11:1532-1538 (Pubitemid 41384338)
4. Millar BC, Loughrey A, Elborn JS et al. Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). J Hosp Infect 2007;67:109-113
5. Hidron AI, Low CE, Honig EG et al. Emergence of community-acquired meticillin-resistant Staphylococcus aureus strain USA300 as a cause of necrotising community-onset pneumonia. Lancet Infect Dis 2009;9:384-392
6. Anon. Four pediatric deaths from community-acquired meticillin-resistant Staphylococcus aureus: Minnesota and North Dakota 1997-1999. MMWR Morb Mortal Wkly Rep 1999; 48. 707-710.
7. Diep BA, Chambers HF, Graber CJ et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148:249-257
8. Thomas S, Karas JA, Emery M et al. Meticillin-resistant Staphylococcus aureus carriage among district nurse patients and medical admissions in a UK district. J Hosp Infect 2007;66:369-373
9. Huang H, Cohen SH, King JH et al. Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis 2008;60:347-350
10. Cooke FJ, Gkrania-Klotsas E, Howard JC et al. Clinical, molecular and epidemiological description of a cluster of community-associated methicillin-resistant Staphylococcus aureus isolates from injecting drug users with bacteraemia. Clin Microbiol Infect 2009; Nov 11 [Epub ahead of print].
11. Cooke FJ, Howard JC, Hugh-Jones C et al. Meticillin-resistant Staphylococcus aureus in the community: homeless are also at risk. J Hosp Infect 2008;68:186-188
12. Davis SL, Perri MB, Donabedian SM et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007; 45:1705-1711
13. Popovich KJ, Weinstein RA. Commentary: the graying of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2009;30:9-12.
14. Seybold U, Kourbatova EV, Johnson JG et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006;42:647-656
15. D'Agata EM, Webb GF, Horn MA et al. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009;48:274-284
16. Klevens RM, Morrison MA, Fridkin SK et al. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis 2006;12:1991-1993
17. Moran GJ, Krishnadasan A, Gorwitz RJ et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006;355:666-674
18. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother 2009;64:441-446
19. Otter JA, Havill NL, Boyce JM et al. Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004-2006: where is USA300 in the UK? Eur J Clin Microbiol Infect Dis 2009;28:835-839
20. Kuehnert MJ, Kruszon-Moran D, Hill HA et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006;193:172-179
21. Schneider-Lindner V, Delaney JA, Dial S et al. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis 2007;13: 994-1000.
22. Abudu L, Blair I, Fraise A et al. Methicillin-resistant Staphylococcus aureus (MRSA): a community-based prevalence survey. Epidemiol Infect 2001;126:351-356
23. Maudsley J, Stone SP, Kibbler CC et al. The community prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in older people living in their own homes: implications for treatment, screening and surveillance in the UK. J Hosp Infect 2004;57:258-262
24. Ellis MW, Hospenthal DR, Dooley DP et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004;39:971-979
25. Fridkin SK, Hageman JC, Morrison M et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-1444
26. Naimi TS, LeDell KH, Como-Sabetti K et al. Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290: 2976-2984
27. Otter JA, French GL. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2006;6:753-755
28. Tristan A, Bes M, Meugnier H et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007;13: 594-600.
29. Health Protection Agency HPS, National Public Health Service for Wales, CDSC Northern Ireland, and the CRDHB. Shooting Up: Infections among Injecting Drug Users in the United Kingdom 2007 London: Health Protection Agency, 2008.
30. Baba T, Takeuchi F, Kuroda M et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002;359:1819-1827
31. Diep BA, Gill SR, Chang RF et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006;367:731-739
32. Holden MT, Feil EJ, Lindsay JA et al. Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc Natl Acad Sci USA 2004;101:9786-9791
33. Hiramatsu K, Cui L, Kuroda M et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. Trends Microbiol 2001;9:486-493
34. Ellington MJ, Perry C, Ganner M et al. Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales. Eur J Clin Microbiol Infect Dis 2009;28:1113-1121
35. Ellington MJ, Ganner M, Warner M et al. Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in England. J Antimicrob Chemother 2010;65:46-50.
36. Nathwani D, Morgan M, Masterton RG et al. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008;61:976-994
37. Gould FK, Brindle R, Chadwick PR et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom. J Antimicrob Chemother 2009;63:849-861